Dear Sir/Madam, Please find enclosed herewith disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 w.r.t appointment of Mr. Anupam Kumar Mishra as an Additional Director ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd's Board of Directors met on 27th August 2025 and approved several items. The 30th Annual General Meeting is scheduled for 24th September 2025 at 11:30 a.m. in Ahmedabad. The Board cleared the Director's Report for FY2024-25 and approved Material Related Party Transactions. It appointed M/s Maulik Bhavsar & Associates as the scrutinizer for the AGM voting process. Most notably, Mr. Anupam Kumar Mishra (DIN: 03629083), aged 55, was appointed as an Additional Non-Executive Independent Director for a five-year term (27th August 2025 to 26th August 2030), subject to shareholder approval. The filing confirms he has not been debarred by SEBI or any other authority.
This is a routine governance update with no material impact on shareholders. The addition of an independent director strengthens board composition, while the AGM notice keeps investors informed of the upcoming meeting. Shareholders should watch for the RPT approvals and Director's Report details at the AGM.